Pulmonary Hypertension Trial, Recruiting (NCT07653958)

Pulmonary Hypertension Trial, Recruiting NCT07653958 Sponsor: Peking Union Medical College Hospital Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07653958 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with pulmonary hypertension (high blood pressure in the lungs), confirmed by a specific heart test called a right heart catheterization showing a certain pressure reading
You have at least one year's worth of medical follow-up records available

Who may not be able to join:

You have incomplete or missing medical records from either the start of your care or during follow-up
You have another serious illness, such as a heart attack condition or cancer, that could significantly affect how long you live
You have another condition, such as severe infection, acute left heart failure, or a sudden blood clot in the lungs, that could significantly affect how the heart and blood vessels are working
You are currently taking medications that can significantly affect how your heart and blood vessels function (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jinmin Peng, MD, Peking Union Medical College Hospital

Phone: 861069155036

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07653958

Sponsor: Peking Union Medical College Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 861069155036

More information: https://clinicaltrials.gov/study/NCT07653958

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with pulmonary hypertension (high blood pressure in the lungs), confirmed by a specific heart test called a right heart catheterization showing a certain pressure reading
You have at least one year's worth of medical follow-up records available

Who may not be able to join:

You have incomplete or missing medical records from either the start of your care or during follow-up
You have another serious illness, such as a heart attack condition or cancer, that could significantly affect how long you live
You have another condition, such as severe infection, acute left heart failure, or a sudden blood clot in the lungs, that could significantly affect how the heart and blood vessels are working
You are currently taking medications that can significantly affect how your heart and blood vessels function (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peking Union Medical College Hospital

Registry

ClinicalTrials.gov

Start date

17 June 2026

Est. completion

30 June 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Pulmonary hypertension crisis; 28 day mortality attributed to pulmonary hypertension crisis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov